Sign in
ARMP Stock Price, Chart, Stats & News
Armata Pharmaceuticals, Inc.
Save
Armata Pharmaceuticals, Inc. (ARMP) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
ARMP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 68.78% |
Operating margin | -636.66% |
Pretax margin | -3544.03% |
Net margin | -3544.03% |
Effective tax rate | – |
ROA | -226.06% |
ROE | 158.91% |
D/E | -1.32x |
Interest coverage ratio | -1.88x |
ARMP valuation
P/E | – |
P/S | 62.52x |
P/B | -1.39x |
P/CF | -11.77x |
P/FCF | -11.66x |
P/OCF | -11.77x |
PEG | 0.01x |
EV multiple | -0.92x |
About
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology enterprise with a global focus on creating specialized bacteriophage therapeutics. Its primary objective is to tackle infections that have developed resistance to standard antibiotics. The company's innovative treatments are developed utilizing its exclusive bacteriophage-based technology platform.
Similar securities
Based on sector and market capitalization
Report issue